For more than four decades, Lilly Oncology has been dedicated to delivering innovative treatment approaches with the goal of improving the outcomes of people living with cancer. We are driven to accelerate the pace and progress of cancer care by developing a portfolio of tailored therapies as vast and unique as the patients themselves. ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company, echoes our commitment to advancing oncology care through targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. The new Lilly Oncology Pipeline app provides all healthcare professionals free access to the Lilly Oncology Clinical Development Program.

Key Features:
- Research: Review drug discovery platforms that are being developed by Lilly Oncology.
- Clinical Trials: Browse Lilly Oncology clinical trials by platform, area of research, or phase in development and access details such as inclusion/exclusion criteria and trial design.
- Pathways of Development: Explore molecules that are in development and see mechanism of action videos.
- Reference: Save pertinent information for fast and easy reference.